<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title></title></head><body><div><p style="margin:0pt; text-align:center"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Written evidence </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">from </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Genzyme</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> Therapeutics</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> Ltd</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> (LTC 31)</span></p><p style="margin:0pt; text-align:center"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Genzyme Therapeutics has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We are focused on rare diseases and multiple sclerosis, and are dedicated to making a positive impact on the lives of the patients and families we serve.</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We would </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">like to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">draw </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the Committee’s </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">attention </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">during</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> this inquiry </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the field of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rare</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">diseases</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">dvances in treatments and technologies </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">mean</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rare </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">conditions that were untreatable </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">just </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">a few </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">year</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">s ago – such as Lysosomal Storage Disorders (LSDs) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">–</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> now fall into the Department of Health definition of ‘long term conditions’</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There are more than 6,000 rare diseases and although individually infrequent, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">collectively they are common; they</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> affect 5</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> per cent</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> of the population</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">are </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">now </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">under the control of a single direct commissioner</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> NHS England</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Due to the low prevalence</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">specialist clinical care for patients with LSDs is concentrated into a few </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">tertiary</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">centres</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However, despite the complex needs of patients treatment and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">personal </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">clinical care is delivered in the community through homecare companies, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">which </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">liaise directly with</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">tertiary </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">centres</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">This service model improves quality of life for patients</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> increases adherence to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">complex </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">treatment</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> allows for combined physiotherapy </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">which is</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> an important </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">treatment adjunct</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and reduces overall costs to the NHS.</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In considering the scope for service re-design,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> we believe </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the Committee should </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">recognise</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> that</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> new treatments and technologies </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">frequently </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">act as the catalyst for </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">such </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">change</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A question t</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">he Committee </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">might like to</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">consider </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">is </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">whether a formal process should exist for initiating </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NHS and s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ocial care </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">service review following </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">positive </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">National Institute for Health and Care Excellence (</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NICE</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> technology appraisal</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">this context</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> savings from new treatments or technologies </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">can </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">often </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">accrue to social care, but </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">upfront </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">costs are borne by the NHS</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> for example in neurological conditions.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Theoretically</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> this is a technical issue </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to be resolved principally by</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> NICE, but </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">in practical terms</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> it is a </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">real </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">barrier </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to service re-design </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">which is </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">created by the NHS and social care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> divide</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The use of patient treatment pathways is increasingly becoming the mechanism to fully describe the potential routes a patient takes through the care system as well as defining the impact of new treatments and technologies. Well-defined multi-stakeholder treatment pathways form the basis of many commissioning strategies and are routinely used in therapeutic areas, such as oncology.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Expansion of the use of treatment pathways would improve stakeholder input and help ensure a broader and more meaningful assessment of new treatments and technologies.</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">N</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">eurological conditions </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">are </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">recognised</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> as having </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">high </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and rising </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rates f</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">or</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> emergency</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> admission</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">re-admission</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, despite growing levels of resource</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, resulting in a</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> previous Parliamentary Committee</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> finding that </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">neurological services represent poor outcomes for people with neurological conditions and poor value for money for the NHS.</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">W</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">e believe that th</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">e Health Committee’s </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">inquiry with a focus on diabetes offers an opportunity to compare and contrast </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">with recent analysis in neurology, which was the condition upon which the 2005 </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the National Service Framework for Long-term Conditions was based.</span></li></ol><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">May 2013</span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Public</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Accounts</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Committee</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">–</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Seventy-Second Report : Services for people with neurological conditions. HC 1760. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Published 13 </span><a name="_GoBack"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">March 2012</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">http://www.publications.parliament.uk/pa/cm201012/cmselect/cmpubacc/1759/175902.htm</span></a></p></body></html>